A Forward Genetic Screen to Identify Druggable Modulators of MECP2 Levels

Huda Zoghbi, MD | Baylor College of Medicine

$733,000 AWARDED

Dr. Zoghbi will screen compounds in search of any that can reduce levels of MeCP2 for the duplication/triplication syndrome. Any positive “hits” could form the foundation for drug discovery efforts.

Current Projects